Predictors of Cognitive Decline in Normal Aging

NCT00094939 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2009-12-14

No results posted yet for this study

Summary

The goal of this project is to develop an early diagnostic test for Alzheimer's disease (AD) by monitoring loss of neurons and brain size reductions over a period of five years.

Conditions

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Mony J. de Leon, Ed.D. · Center for Brain Health, Silberstein Institute

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00094939 on ClinicalTrials.gov